During diabetes, PI3 kinase pathway is typically down-regulated and therefore, GSK3 activity may be up-regulated, which could drive phosphorylation of Tau in diabetes (Hooper et al., 2008). This evidence concerns the gene MAPT and diabetes mellitus.